Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The official judgmental map of Cannes Lions 2026
This map won’t tell you where to go during Cannes Lions. It will tell you where you actually are.
The definitive Digiday guide to what’s in and out at Cannes 2026
Here’s what’s in and out for the Cannes Lions International Festival of Creativity.
As AI reshapes search, TikTok turns discovery into a performance pitch
The platform argues rising search activity is evidence that discovery is increasingly driving performance outcomes advertisers expect.